Combined Live Measles, Mumps, Rubella Vaccine

Abstract
A combined live attenuated measles, mumps, rubella vaccine was administered to 40 susceptible (seronegative) infants, 12 to 26 months of age. The antibody responses to the three viruses were excellent and the vaccine was well tolerated.